Market revenue in 2020 | USD 1,166.4 million |
Market revenue in 2028 | USD 1,872.6 million |
Growth rate | 6.1% (CAGR from 2020 to 2028) |
Largest segment | Mental health |
Fastest growing segment | CNS Cancer |
Historical data | 2018 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Neurovascular Diseases, CNS Trauma, Mental Health, Neurodegenerative Diseases, Infectious Diseases, CNS Cancer |
Key market players worldwide | Biogen Inc, Otsuka Pharmaceutical, Eli Lilly and Co, Merck & Co Inc, AstraZeneca PLC, Novartis AG ADR, Teva Pharmaceutical Industries Ltd, Johnson & Johnson, Pfizer Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to central nervous system therapeutic market will help companies and investors design strategic landscapes.
Mental health was the largest segment with a revenue share of 49.55% in 2020. Horizon Databook has segmented the Mexico central nervous system therapeutic market based on neurovascular diseases, cns trauma, mental health, neurodegenerative diseases, infectious diseases, cns cancer covering the revenue growth of each sub-segment from 2018 to 2028.
The prevalence of common mental health disorders like anxiety and depression in Mexico has been reported to be at 14.9% and 4%, respectively. In another study published by the official scientific journal of the Mexican National Academy of Medicine, One of the main factors behind the rise of neurodegenerative diseases such as Alzheimer’s in the country
is its populations’ lifetime exposure to fine particles such as (PM2.5) and ozone (O3) above the U.S. EPA standards along with rapidly ageing population. Hence, the CNS therapeutics market is expected to grow steadily over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico central nervous system therapeutic market , including forecasts for subscribers. This country databook contains high-level insights into Mexico central nervous system therapeutic market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account